Cvijic Christine Mikail
SEC CIK 1543663 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | Pres, CFO, Dir | 84.0K | $491.5K | $976.3K | 11 | 2024-03-13 | 2026-07-06 |
Most active insiders at NGNE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cvijic Christine Mikail | Pres, CFO, Dir | — | $900.0K |
| 2 | Cobb Stuart | CSO | — | $141.4K |
| 3 | McMinn Rachel | CEO, Dir | — | $74.0K |
| 4 | Jordan Julie | Chief Medical Off | — | $18.1K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-07-07 21:08 | 2026-07-06+ | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO, Dir | S - Sale | $36.12 | -4,800 | 84.0K | -5% | -$173.4K |
| MT | 2026-07-02 18:42 | 2026-07-01+ | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO, Dir | S - Sale | $34.71 | -4,800 | 88.8K | -5% | -$166.6K |
| MT | 2026-05-08 11:51 | 2026-05-06 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO, Dir | S - Sale | $31.25 | -9,600 | 93.6K | -9% | -$300.0K |
| 2026-03-30 | 2026-03-26 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | S - Sale | $21.62 | -2,558 | 103.2K | -2% | -$55.3K | |
| M | 2026-03-17 | 2026-03-13 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | S - Sale | $20.81 | -4,045 | 107.5K | -4% | -$84.2K |
| 2026-03-03 | 2026-02-27 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | S - Sale | $25.11 | -4,800 | 109.8K | -4% | -$120.5K | |
| D | 2026-02-24 | 2026-02-20 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | A - Grant | $0.00 | +22.0K | 114.6K | +24% | $0 |
| D | 2025-03-28 | 2025-03-26 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | A - Grant | $0.00 | +20.3K | 92.6K | +28% | $0 |
| 2025-03-17 | 2025-03-13 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | S - Sale | $16.94 | -4,501 | 72.3K | -6% | -$76.2K | |
| 2024-11-25 | 2024-11-22 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | P - Purchase | $20.48 | +24.0K | 76.8K | +45% | +$491.5K | |
| D | 2024-03-14 | 2024-03-13 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Pres, CFO | A - Grant | $0.00 | +31.9K | 52.8K | +152% | $0 |
Purchase Sale Sale after option exercise All abbreviations